Advances in basic and clinical research in laminopathies

Acta Myologica

Volumn 32, Issue 1, 2013, Pages 18-22

  Politano, Luisa ^a   Carboni, Nicola ^b   Madej Pilarczyk, Agnieszka ^c   Marchel, Michael ^d   Nigro, Gerardo ^a   FidziaNska, Anna ^c   Opolski, Grzegorz ^d   Hausmanowa Petrusewicz, Irena ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Emery Dreifuss muscular dystrophy; Laminopathies; LMNA A C gene

Indexed keywords

EMERIN; LAMIN A; LAMIN;

CHROMATIN; CLINICAL RESEARCH; CONFERENCE PAPER; EPIGENETICS; GENE; GENE MUTATION; GENE THERAPY; HUMAN; LAMIN GENE; LAMINOPATHY; MUSCULAR DYSTROPHY; PATHOGENESIS; PHENOTYPE; PREMATURE AGING; EMERY-DREIFUSS MUSCULAR DYSTROPHY; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENETICS; LAMINOPATHIES; LIPODYSTROPHY; LMNA A/C GENE; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; REVIEW; PROCEDURES;

EMERY-DREIFUSS MUSCULAR DYSTROPHY; LAMINOPATHIES; LMNA A/C GENE;

BIOMEDICAL RESEARCH; GENETIC PREDISPOSITION TO DISEASE; GENETIC TECHNIQUES; HUMANS; LAMINS; LIPODYSTROPHY;

EID: 84891724506     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Zuela N, Bar DZ, Gruenbaum Y. Lamins in development, tissue maintenance and stress. EMBO Rep 2012;13:1070-8.
2. Bank EM, Gruenbaum Y. Caenorhabditis elegans as a model system for studying the nuclear lamina and laminopathic diseases. Nucleus 2011;2:350-7.
3. Broers JL, Ramaekers FC, Bonne G, et al. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 2006;86:967-1008.
4. Hutchison CJ. The role of DNA damage in laminopathy progeroid syndromes. Biochem Soc Trans 2011;39:1715-8.
5. Liu B, Wang J, Chan KM, et al. Genomic instability in laminopathy-based premature aging. Nat Med 2005;11:780-5.
6. Herskind AM, McGue M, Holm NV, et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 1996;97:319-23.
7. Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulinlike growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008;105:3438-42.
8. Kitada M, Kume S, Takeda-Watanabe A, et al. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013;124:153-64.
9. Calvanese V, Lara E, Kahn A, et al. The role of epigenetics in aging and age-related diseases. Ageing Res Rev 2009;8:268-76.
10. D'Aquila P, Rose G, Bellizzi D, et al. Epigenetics and aging. Maturitas 2013;74:130-6.
11. Polosak J, Roszkowska-Gancarz M, Kurylowicz A, et al. Decreased expression and the Lys751Gln polymorphism of the XPD gene are associated with extreme longevity. Biogerontology 2010;11:287-97.
12. Polosak J, Kurylowicz A, Roszkowska-Gancarz M, et al. Aging is accompanied by a progressive decrease of expression of the WRN gene in human blood mononuclear cells. J Gerontol A Biol Sci Med Sci 2011;66:19-25.
13. Pekovic V, Hutchison CJ. Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches. J Anat 2008;213:5-25.
14. Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008;10:452-9.
15. Cowan CA, Klimanskaya I, McMahon J. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004;350:1353-6.
16. Takashima Y, Era T, Nakao K. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129:1377-88.
17. Worman HJ, Foisner R. The nuclear envelope from basic biology to therapy. Biochem Soc Trans 2010;38:253-6.
18. Pilat U, Dechat T, Bertrand AT. Muscle dystrophy-causing ?K32 lamin A/C mutant does not impair functions of nucleoplasmic LAP2a-lamin A/C complexes in mice. J Cell Sci 2013 Feb 26.
19. Dubinska-Magiera M, Zaremba-Czogalla M, Rzepecki R. Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease. Cell Mol Life Sci 2012 Nov 10. (Epub ahead of print)
20. Zaremba-Czogalla M, Dubinska-Magiera M, Rzepecki R. Laminopathies: the molecular background of the disease and the prospects for its treatment. Cell Mol Biol Lett 2011;16:114-48.
21. Bonne G, Di Barletta MR, Varnous S, et al Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999;21:285-8.
22. Meune C, Van Berlo JH, Anselme F, et al Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006;354:209-10.
23. Pasotti M, Klersy C, Pilotto A, et al. Long term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 2008;52:1250-60.
24. van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 2012;59:493-500.
25. Maraldi NM, Merlini L. Emery Dreifuss muscular dystrophy. In: Engel AG, Franzini-Armstrong C. Myology, Vol. 2. New York: McGraw-Hill Medical Publishing Division 2004; chpt. 35, pp. 961-1026.
26. Ditmer T, Misteli T. The Lamin protein family. Genome Biology 2011;12:222-35.
27. van der Kooi AJ, Ledderhof TM, de Voogt WG, et al. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol 1996;39:636-42.
28. Quijano-Roy S, Mbieleu B, Bonnemann CG, et al. De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol. 2008;64:177-86.
29. Fatkin D, Mac Rae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1714-24.
30. Choi JC, Muchir A, Wu W, et al. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med 2012;4:144ra102.
31. Wu W, Muchir A, Shan J, et al. Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 2011;123:53-61.
32. Nigro G, Russo V, Rago A, et al. Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. Kardiol Pol 2012;70:1154-9.
33. Russo V, Rago A, Politano L, et al. Increased dispersion of ventricular repolarization in Emery Dreifuss muscular dystrophy patients. Med Sci Monit 2012;18:CR643-7.
34. Carboni N, Porcu M, Mura M, et al. Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement. Muscle Nerve 2010;41:85-91.
35. Carboni N, Mura M, Marrosu G, et al. Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation. Neuromuscul Disord 2008;18:291-8.
36. Benedetti S, Bernasconi P, Bertini E, et al. The empowerment of translational research: lessons from laminopathies. Orphanet J Rare Dis 2012;7:37.
37. Lattanzi G, Benedetti S, Bertini E, et al. Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol 2011;30:138-43.
38. Hausmanowa-Petrusewicz I. Laminopathies: a common denominator of many disorders (a new chapter of neuromyology and beyond). Neurol Neurochir Pol 2004;38:1-2.
39. Hausmanowa-Petrusewicz I, Madej-Pilarczyk A, Marchel M, et al. Emery-Dreifuss dystrophy: a 4-year follow-up on a laminopathy of special interest. Neurol Neurochir Pol 2009;43:415-20.
40. Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, et al. Osteopontin-a fibrosis-related marker-in dilated cardiomyopathy in patients with Emery-Dreifuss muscular dystrophy. Scand J Clin Lab Invest 2011;71:658-62.
41. Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, et al. Circulating tenascin-C levels in patients with dilated cardiomyopathy in the course of Emery-Dreifuss muscular dystrophy. Clin Chim Acta 2011;412:1533-8.
42. Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, et al. Matrix metalloproteinases in serum of Emery-Dreifuss muscular dystrophy patients. Acta Biochim Pol 2009;56:717-22.
43. Fidzianska A, Glinka Z, Kaminska A, et al. Altered distribution of lamin and emerin in muscle nuclei of sIBM patients. Clin Neuropathol 2008;27:424-9.
44. Madej-Pilarczyk A, Rosinska-Borkowska D, Rekawek J, et al. Progeroid syndrome with scleroderma-like skin changes associated with homozygous R435C LMNA mutation. Am J Med Genet A 2009;149A:2387-92.